Through partnership with thought leaders across North America, Cochlear is excited to share the updated white paper, “2024 Clinical Recommendations for the Treatment of Unilateral Hearing Loss/Single-Sided Deafness with Cochlear Implantation,” which discusses clinical recommendations for the treatment of unilateral hearing loss/Single-Sided Deafness with cochlear implantation in adults. This paper aims to provide a comprehensive overview of the treatment of Single-Sided Deafness (SSD) with a cochlear implant, drawing on recommendations from industry experts.
One key aspect discussed is the adult treatment pathway and candidacy considerations which highlights the criteria that determine a patient’s suitability for a cochlear implant. This includes an in-depth look at patient selection criteria, quality of life assessments, patient motivation, and the importance of establishing realistic expectations for performance and rehabilitation. The figure below summarizes key considerations in the evaluation process which are discussed in detail in the paper.
Next, we delve into the essential aspects of programming a cochlear implant for patients with SSD. Clinical considerations necessary to optimize the implant’s performance and ensure the best possible outcomes for patients are reviewed.
Finally, we discuss guidance for clinical follow-up which has been updated to align with current Care Model standards while ensuring optimal outcomes for adults with SSD. Recommended follow-up from thought leaders is outlined in the following image and further discussed in the white paper.
By addressing these key areas, the updated white paper aims to provide valuable insights and practical guidance for surgeons and audiologists involved in the treatment of SSD with cochlear implants, ultimately enhancing patient care and outcomes. Check out the full article below.
